TOKYO, Oct 20, 2023 (BSS/AFP) - Daiichi Sankyo shares soared on Friday after
the Japanese pharma group announced a cancer drug deal with Merck worth up to
$22 billion.

Under the agreement announced by both firms, US giant Merck will pay Daiichi
Sankyo up to $22 billion for the rights to several cancer drugs in
development.